Latest Kaiser Health News Stories
To keep costs down, Blue Shield of California next year will scale back on a program allowing members to receive a wide range of care beyond the state’s borders. Customers with individual plans mostly won’t be able to get coverage out of state except for emergencies or other exceptional circumstances.
UnitedHealthcare has put the skids on offering SilverSneakers, the nation’s fitness program for seniors, as part of its benefit packages. A look at why and some alternatives.
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
A California college professor never imagined that trying to figure out what was causing her rash could add up to such a huge bill.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Insurance companies profit from government contracts but are subject to little oversight of how they spend the money or care for patients. The expansion of Medicaid under the Affordable Care Act has only exacerbated the problem.
The private health plans that are an alternative to government-run Medicare continue to grow despite the Affordable Care Act’s cuts of billions of dollars in funding.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the Trump administration’s announcement that average premium prices are falling on the Obamacare marketplaces, the effort by Senate Democrats to reverse rules on short-term health insurance and the focus on protections for people with preexisting conditions in the run-up to midterm elections.
Some private Medicare Advantage plans are offering large physician-management companies more money upfront and control of their patients’ care, but the doctors are responsible for staying within the budget.
Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.